NCT05653271
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05653271
Title ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acepodia Biotech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
AdventHealth Orlando Orlando Florida 32804 United States Details
Emory University Atlanta Georgia 30322 United States Details
Indiana University Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Queen Mary Hospital Hong Kong Hong Kong Hong Kong Details
Kaohsiung Chang-Gung Memorial Hospital Kaohsiung City Kaohsiung Taiwan Details
National Cheng Kung University Hospital Tainan Tainan Taiwan Details
National Taiwan University Hospital Taipei Taipei Taiwan Details
Ministry of Health and Welfare Shuang-Ho Hospital New Taipei City Taiwan Taiwan Details
Taichung Veterans General Hospital Taichung Taiwan Taiwan Details
Tamsui MacKay Memorial Hospital New Taipei City Taiwan Details
Linkou Chang-Gung Memorial Hospital Taoyuan City Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field